Who Owns AstraZeneca Stock?
NYSE: AZNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 158.78 0.00%
Ownership breakdown
- Held by institutions
- 65.07%
- Held by insiders
- 0.05%
- Institutional holders
- 2,527
- Institutions 65.1%
- Insiders 0.1%
- Public and other 34.9%
Who owns AstraZeneca stock?
Institutional investors own about 65.1% of AstraZeneca's shares, spread across 2,527 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.05% of AZN.
The largest institutional holders are Investor AB (3.33%), Vanguard Capital Management LLC (2.93%) and Capital International Investors (2.23%). Together, the top 10 institutions control 20.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their AZN positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AZN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Investor AB | 51.59M | 3.33% | 0.0% |
| Vanguard Capital Management LLC | 45.39M | 2.93% | +0.8% |
| Capital International Investors | 34.58M | 2.23% | +0.5% |
| NORGES BANK | 33.86M | 2.18% | +5207.1% |
| Capital World Investors | 30.08M | 1.94% | +6.4% |
| FMR, LLC | 28.90M | 1.86% | -2.4% |
| Wellington Management Group, LLP | 28.54M | 1.84% | +20.1% |
| Legal & General Group PLC | 25.75M | 1.66% | -0.4% |
| JPMORGAN CHASE & CO | 19.20M | 1.24% | +3.3% |
| Vanguard Asset Management, Ltd | 18.71M | 1.21% | +1.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AZN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 22.05M | 1.42% |
| NEW PERSPECTIVE FUND | 16.85M | 1.09% |
| VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund | 14.67M | 0.95% |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 11.92M | 0.77% |
| iShares Trust-iShares Core MSCI EAFE ETF | 11.31M | 0.73% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 10.30M | 0.66% |
| EuroPacific Growth Fund-EUPAC Fund | 9.86M | 0.64% |
| Goldman Sachs TRT II-Goldman Sachs GQG Part. Intl Opportunities Fd. | 8.96M | 0.58% |
| Capital Income Builder | 8.39M | 0.54% |
| Fidelity Concord Street Trust-Fidelity International Index Fund | 5.88M | 0.38% |
Frequently asked questions
Who is the largest shareholder of AstraZeneca?
Investor AB is the largest institutional shareholder of AZN, owning 3.33% of shares outstanding (51.59M shares) as of its latest 13F filing.
What percentage of AstraZeneca is owned by institutions?
Institutions own about 65.1% of AZN shares and 65.1% of the public float.
How much of AstraZeneca do insiders own?
Insiders, such as officers and directors, own about 0.05% of AZN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.